RPS29P2

Across TCGA pan-cancer cohorts, RPS29P2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPS29P2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where RPS29P2 RNA is repressed in tumor relative to normal tissue. In most cancer types RPS29P2 is over-expressed in tumor, although a few such as BRCA and KIRC show the opposite, repressed pattern.

BRCA, KIRC, and KIRP are the cancer types where RPS29P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS29P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	All	−0.407	<.001	6	view →
KIRC	Male	All	−0.110	<.001	6	view →
KIRP	All	All	−0.118	.008	1	view →
LUSC	All	All	+0.070	.039	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RPS29P2–BRCA

Open the BRCA breakdown →